Sales and Marketing

Showing 15 posts of 11527 posts found.

EMA panel gives positive opinion for Roche’s Zelboraf

December 16, 2011 Sales and Marketing EMA, Roche, Zelboraf

The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf.  The European regulator’s Committee for Medicinal …

Amgen’s chief executive and chairman Kevin Sharer to retire

December 16, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen

Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …

Merck and Roche begin combination hep C trial

December 16, 2011 Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …

BMS in cholesterol alliance with China’s Simcere

December 16, 2011 Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets

Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …

Lisa Anson appointed as president of AstraZeneca’s UK marketing

December 15, 2011 Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Lisa Anson

AstraZeneca has appointed Lisa Anson as its new president for the firm’s UK marketing company, effective 1 January 2012.  Anson …

Optimising your brand – one bite at a time

December 15, 2011 Business Services, Medical Communications, Sales and Marketing Alex Blyth, MSI, brand, marketing

Brand managers invest a huge amount of time every year preparing brand plans – but often without really knowing what …

Debts will force hospitals to close

December 15, 2011 Sales and Marketing NHS, hospitals, king's fund

Around twenty hospitals in England may have to merge or close because of major financial problems, according to a committee …

Roche makes changes in its corporate executive committee

December 15, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche

Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …

Frazier defends R&D investment and attacks price pressure

December 14, 2011 Research and Development, Sales and Marketing Merck, R&D productivity, prices

Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …

NICE rejects AstraZeneca’s breast cancer drug

December 14, 2011 Sales and Marketing AstraZeneca, Faslodex, NICE

NICE has made its final decision not to recommended AstraZeneca’s breast cancer drug Faslodex, as it says the drug is …

NICE gives partial recommendation for RoActemra

December 14, 2011 Sales and Marketing RoActemra, Roche

Roche’s patient access scheme has persuaded NICE to recommend RoActemra in childhood arthritis under certain circumstances. In its final guidance …

GSK’s Stiefel accused of shares fraud

December 13, 2011 Sales and Marketing GSK, SEC, Stiefel, fraud

The US financial regulator has charged a subsidiary of GlaxoSmithKline with defrauding staff by buying back shares from them at …

Ian Read elected as chairman of the board at Pfizer

December 13, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …

Abbott signs $400 million deal with Reata

December 13, 2011 Research and Development, Sales and Marketing Abbott

Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …

Pfizer awaits verdict on contaminated site clean-up plan

December 13, 2011 Manufacturing and Production, Sales and Marketing FDA, Pfizer, manufacturing

The US Environmental Protection Agency is due to deliver a verdict on a $205 million proposal by Pfizer to clean …
The Gateway to Local Adoption Series

Latest content